Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact - Global Forecast to 2026
The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.
Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.
The sterilization segment is expected to grow at the highest CAGR during the forecast period
Based on the products and services used in the control of HAIs, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.
The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control market
Based on end user, the hospital acquired infection control market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories). The hospitals & ICUs segment accounted for the largest share of the hospital acquired infection control market in 2020. Growth in this market is majorly attributed to the rising prevalence of HAIs, increasing adoption of single-use medical devices, and rising number of surgical procedures worldwide.
Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control market
The Asia Pacific hospital acquired infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the hospital acquired infection control market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.
Break of primary participants was as mentioned below:
The key players operating in the hospital acquired infection control market include STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany).
Research Coverage:
The report analyzes the hospital acquired infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as products and services, end user, and region. The report also includes a product portfolio matrix of various hospital acquired infection services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product & service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.
The sterilization segment is expected to grow at the highest CAGR during the forecast period
Based on the products and services used in the control of HAIs, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.
The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control market
Based on end user, the hospital acquired infection control market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories). The hospitals & ICUs segment accounted for the largest share of the hospital acquired infection control market in 2020. Growth in this market is majorly attributed to the rising prevalence of HAIs, increasing adoption of single-use medical devices, and rising number of surgical procedures worldwide.
Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control market
The Asia Pacific hospital acquired infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the hospital acquired infection control market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
The key players operating in the hospital acquired infection control market include STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany).
Research Coverage:
The report analyzes the hospital acquired infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as products and services, end user, and region. The report also includes a product portfolio matrix of various hospital acquired infection services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product & service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global hospital acquired infection control market. The report analyzes this market by products and services, and end user
- Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global hospital acquired infection control market
- Market Development: Comprehensive information on the lucrative emerging markets by products and services, and end user
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global hospital acquired infection control market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global hospital acquired infection control market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET (2021–2026)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2021 VS. 2026 (USD MILLION)
FIGURE 15 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHIC ANALYSIS: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
4 PREMIUM INSIGHTS
4.1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW
FIGURE 17 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER AND COUNTRY
FIGURE 18 HOSPITALS & ICUS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET IN 2020
4.3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
4.4 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION (2019–2026)
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET DURING THE FORECAST PERIOD
4.5 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 High incidence of hospital-acquired infections (HAIs)
5.2.1.2 Increasing number of surgical procedures
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED
5.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases
5.2.1.4 Technological advancements in sterilization equipment
5.2.1.5 Growing awareness of environmental & personal hygiene due to COVID-19
5.2.2 MARKET RESTRAINTS
5.2.2.1 Concerns regarding the safety of reprocessed instruments
5.2.2.2 Adverse effects of chemical disinfectants
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare settings
5.2.3.2 Rising adoption of single-use medical nonwovens and devices
5.2.3.3 Growing healthcare industry and outsourcing of operations to emerging countries
FIGURE 22 INDIA: HEALTHCARE SECTOR GROWTH TREND (USD BILLION)
FIGURE 23 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES
5.2.4 MARKET CHALLENGES
5.2.4.1 Complications associated with hospital-acquired infection control procedures
5.2.4.2 End-user noncompliance with sterilization standards
TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS
5.2.4.3 Development of alternative technologies for surface disinfection
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF STERILIZATION USING NO2
6.2.2 ROBOTICS UTILIZATION FOR DISINFECTION
6.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS
6.2.4 LAYERING/BUNDLING IN INFECTION PREVENTION
6.3 REGULATORY ANALYSIS
6.3.1 REGULATORY JURISDICTION
TABLE 6 FDA- AND EPA-REGISTERED PRODUCT CATEGORIES
6.3.2 BY REGION
6.3.2.1 North America
6.3.2.1.1 US
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
6.3.2.1.2 Canada
TABLE 7 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING
6.3.2.2 Europe
TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION
FIGURE 25 CE MARKING FOR REPROCESSED MEDICAL DEVICES
6.3.2.3 Asia Pacific
6.3.2.3.1 Japan
TABLE 9 SOME GUIDELINES FOLLOWED UNDER ISO IN JAPAN
TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES
6.3.2.3.2 Australia
6.3.2.4 Latin America
6.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19
6.3.3.1 Sterilizers
TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS
6.3.3.2 Disinfectant devices
TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES
6.4 TECHNOLOGY ANALYSIS
6.4.1 KEY TECHNOLOGIES
6.4.2 COMPLEMENTARY TECHNOLOGIES
6.4.3 ADJACENT TECHNOLOGIES
6.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 PORTER’S FIVE FORCES ANALYSIS (2020): HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
6.5.1 THREAT FROM NEW ENTRANTS
6.5.2 THREAT FROM SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
6.6 ECOSYSTEM ANALYSIS
FIGURE 26 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS
6.7 VALUE CHAIN ANALYSIS
FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS
6.8 TRADE DATA
6.8.1 EXPORT DATA (USD)
6.8.2 IMPORT DATA (USD)
6.9 PATENT ANALYSIS
6.9.1 PATENT PUBLICATION TRENDS FOR HOSPITAL-ACQUIRED INFECTION CONTROL
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2021)
6.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021)
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021)
TABLE 14 LIST OF FEW PATENTS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, 2020–2021
6.10 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
7 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS
TABLE 16 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
7.2 PROTECTIVE BARRIERS
7.2.1 RISING ADOPTION OF NONWOVENS IN SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH
TABLE 17 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 STERILIZATION
TABLE 18 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 19 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1 STERILIZATION EQUIPMENT
7.3.1.1 Effectiveness of sterilization equipment in sterilizing heat-sensitive products is expected to boost the market growth
TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 STERILIZATION SERVICES
7.3.2.1 Increasing prevalence of HAIs and rising surgical interventions to drive market growth
TABLE 21 STERILIZATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 STERILIZATION CONSUMABLES & ACCESSORIES
7.3.3.1 Low cost and efficacy of sterilization consumables & accessories in monitoring the sterilization process to drive market growth
TABLE 22 STERILIZATION CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 DISINFECTANTS
TABLE 23 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION
TABLE 24 COMMON DISINFECTANTS USED IN HEALTHCARE SETTINGS
TABLE 25 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 DISINFECTANTS, BY TYPE
TABLE 26 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2019–2026 (USD MILLION)
7.4.1.1 Hand disinfectants
7.4.1.1.1 Increasing availability of various hand disinfection options to aid market growth
TABLE 27 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 28 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.2 Surface disinfectants
7.4.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff
TABLE 29 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 30 SURFACE DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.3 Skin disinfectants
7.4.1.3.1 Growing awareness about different HAIs and SSIs to aid market growth
TABLE 31 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 32 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.4 Instrument disinfectants
7.4.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market
TABLE 33 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT AND THE REQUIRED LEVEL OF REPROCESSING
TABLE 34 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 DISINFECTANTS, BY FORMULATION
TABLE 35 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2019–2026 (USD MILLION)
7.4.2.1 Liquid disinfectants
7.4.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces
TABLE 36 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 37 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2.2 Disinfectant wipes
7.4.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens
TABLE 38 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS
TABLE 39 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2.3 Disinfectant sprays
7.4.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters
TABLE 40 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS
TABLE 41 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 DISINFECTORS
7.5.1 GROWING NEED TO REDUCE THE SPREAD OF HAIS IS DRIVING MARKET GROWTH
TABLE 42 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTORS, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 ENDOSCOPE REPROCESSING PRODUCTS
7.6.1 INCREASING NUMBER OF ENDOSCOPY PROCEDURES CONDUCTED TO DRIVE MARKET GROWTH
TABLE 43 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION)
7.7 OTHER INFECTION CONTROL PRODUCTS
TABLE 44 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER INFECTION CONTROL PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION)
8 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER
8.1 INTRODUCTION
TABLE 45 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 IMPACT OF COVID-19 ON THE END USERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
8.3 HOSPITALS & INTENSIVE CARE UNITS (ICUS)
8.3.1 HIGH PREVALENCE OF HAIS TO DRIVE THE DEMAND FOR DISINFECTION AND STERILIZATION PRODUCTS AMONG HOSPITALS & INTENSIVE CARE UNITS
TABLE 46 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & INTENSIVE CARE UNITS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 AMBULATORY SURGERY & DIAGNOSTIC CENTERS
8.4.1 GROWING NUMBER OF OUTPATIENTS AND AWARENESS OF MINIMALLY INVASIVE SURGERIES IS EXPECTED TO PROPEL MARKET GROWTH
TABLE 47 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGERY & DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 NURSING HOMES & MATERNITY CENTERS
8.5.1 GROWING NEED TO ENSURE THE SAFETY OF ELDERLY PATIENTS AND RISING SURGICAL PROCEDURES IN WOMEN TO DRIVE THE ADOPTION OF HAI CONTROL PRODUCTS IN THIS END-USER SEGMENT
TABLE 48 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR NURSING HOMES & MATERNITY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER END USERS
TABLE 49 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
9 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 31 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020)
TABLE 50 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
9.3 NORTH AMERICA
TABLE 51 NATIONAL ACUTE CARE HOSPITAL HAI METRICS
FIGURE 32 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
TABLE 52 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 54 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 57 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 US
9.3.1.1 Increasing prevalence of HAIs, high R&D expenditure, and the presence of well-established pharmaceutical, medical devices, and hospital industries to drive market growth
TABLE 59 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 60 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 US: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 US: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 64 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 CANADA
9.3.2.1 High prevalence of HAIs to increase the adoption of infection control products in the country
TABLE 65 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 66 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 CANADA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 70 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 EUROPE
TABLE 71 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 72 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 73 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 EUROPE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 77 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 GERMANY
9.4.1.1 Rising incidence of nosocomial infections and chronic diseases to drive growth in the market in Germany
TABLE 78 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 79 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 GERMANY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 GERMANY: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 83 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 FRANCE
9.4.2.1 High healthcare spending in the country to favor market growth
TABLE 84 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 85 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 FRANCE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 FRANCE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 89 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 UK
9.4.3.1 Rising number of surgical procedures to drive the market growth in the UK
TABLE 90 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 91 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 UK: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 UK: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 95 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 ITALY
9.4.4.1 Improving quality and accessibility to medical care and technologies to support market growth
TABLE 96 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 97 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 99 ITALY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ITALY: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 101 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.5 SPAIN
9.4.5.1 Rising incidence of chronic disorders to drive market growth
TABLE 102 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 103 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 SPAIN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 SPAIN: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 107 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.6 REST OF EUROPE
TABLE 108 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 109 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ROE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 113 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
TABLE 114 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 JAPAN
9.5.1.1 Rising standard of care due to the increasing healthcare expenditure to support market growth
TABLE 121 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 122 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 CHINA
9.5.2.1 China is the fastest-growing market for hospital-acquired infection control products and services
FIGURE 34 CHINA: TOTAL NUMBER OF HOSPITAL BEDS (2009–2019)
TABLE 127 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 128 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 CHINA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 CHINA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 132 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 INDIA
9.5.3.1 Large patient population to support the growth of the hospital-acquired infection control market in the country
TABLE 133 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 134 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 INDIA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 INDIA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 138 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.4 REST OF ASIA PACIFIC
FIGURE 35 NUMBER OF INBOUND VISITORS TO SOUTH KOREA FROM
2000 TO 2020 (IN MILLIONS)
TABLE 139 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 140 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 ROAPAC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 ROAPAC: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 144 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 LATIN AMERICA
9.6.1 RISING NUMBER OF COSMETIC SURGERIES IN THE REGION TO DRIVE THE ADOPTION OF INFECTION CONTROL PRODUCTS
TABLE 145 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 146 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 LATIN AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 LATIN AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 150 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.7 MIDDLE EAST & AFRICA
9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
TABLE 151 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 37 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2020
TABLE 157 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE BENCHMARKING
10.5.1 COMPANY PRODUCT/SERVICE FOOTPRINT
TABLE 158 COMPANY PRODUCT OFFERING FOOTPRINT (20 COMPANIES)
TABLE 159 COMPANY END-USER FOOTPRINT (20 COMPANIES)
TABLE 160 COMPANY REGION FOOTPRINT (20 COMPANIES)
10.6 COMPETITIVE LEADERSHIP MAPPING
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 38 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 161 PRODUCT LAUNCHES & APPROVALS, 2018–2021
10.7.2 DEALS
TABLE 162 DEALS, 2018–2021
10.7.3 OTHER DEVELOPMENTS
TABLE 163 OTHER DEVELOPMENTS, 2018–2021
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 STERIS PLC
TABLE 164 STERIS PLC: BUSINESS OVERVIEW
FIGURE 39 STERIS PLC: COMPANY SNAPSHOT (2021)
11.1.2 SOTERA HEALTH COMPANY
TABLE 165 SOTERA HEALTH COMPANY: BUSINESS OVERVIEW
FIGURE 40 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT (2020)
11.1.3 GETINGE AB
TABLE 166 GETINGE AB: BUSINESS OVERVIEW
FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020)
11.1.4 ADVANCED STERILIZATION PRODUCTS (ASP)
TABLE 167 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW
FIGURE 42 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020)
11.1.5 ECOLAB INC.
TABLE 168 ECOLAB INC.: BUSINESS OVERVIEW
FIGURE 43 ECOLAB INC.: COMPANY SNAPSHOT (2020)
11.1.6 3M COMPANY
TABLE 169 3M COMPANY: BUSINESS OVERVIEW
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2020)
11.1.7 MATACHANA GROUP
TABLE 170 MATACHANA GROUP: BUSINESS OVERVIEW
11.1.8 MMM GROUP
TABLE 171 MMM GROUP: BUSINESS OVERVIEW
11.1.9 BELIMED AG (A SUBSIDIARY OF METALL ZUG GROUP)
TABLE 172 BELIMED AG: BUSINESS OVERVIEW
FIGURE 45 METALL ZUG GROUP: COMPANY SNAPSHOT (2020)
11.1.10 RECKITT BENCKISER
TABLE 173 RECKITT BENCKISER: BUSINESS OVERVIEW
FIGURE 46 RECKITT BENCKISER: COMPANY SNAPSHOT (2020)
11.1.11 METREX RESEARCH LLC (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 174 METREX RESEARCH: BUSINESS OVERVIEW
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.12 MIELE GROUP
TABLE 175 MIELE GROUP: BUSINESS OVERVIEW
FIGURE 48 MIELE GROUP: COMPANY SNAPSHOT (2020)
11.1.13 PAL INTERNATIONAL
TABLE 176 PAL INTERNATIONAL: BUSINESS OVERVIEW
11.1.14 MELAG MEDIZINTECHNIK GMBH & CO. KG
TABLE 177 MELAG MEDIZINTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
11.1.15 CONTEC, INC.
TABLE 178 CONTEC, INC.: BUSINESS OVERVIEW
11.1.16 MEDALKAN
TABLE 179 MEDALKAN: BUSINESS OVERVIEW
11.1.17 SYSTEC GMBH
TABLE 180 SYSTEC GMBH: BUSINESS OVERVIEW
11.1.18 C.B.M. S.R.L. MEDICAL EQUIPMENT
TABLE 181 C.B.M. S.R.L. MEDICAL EQUIPMENT: BUSINESS OVERVIEW
11.1.19 CONTINENTAL EQUIPMENT COMPANY
TABLE 182 CONTINENTAL EQUIPMENT COMPANY: BUSINESS OVERVIEW
11.1.20 BETA-GAMMA-SERVICE GMBH & CO. KG
TABLE 183 BETA-GAMMA-SERVICE GMBH & CO. KG: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 MIDWEST STERILIZATION CORPORATION
11.2.2 BLUE LINE STERILIZATION SERVICES LLC
11.2.3 STERIPACK GROUP
11.2.4 STERI-TEK
11.2.5 STERILIZATION SERVICES
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET (2021–2026)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2021 VS. 2026 (USD MILLION)
FIGURE 15 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHIC ANALYSIS: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
4 PREMIUM INSIGHTS
4.1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW
FIGURE 17 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER AND COUNTRY
FIGURE 18 HOSPITALS & ICUS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET IN 2020
4.3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
4.4 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION (2019–2026)
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET DURING THE FORECAST PERIOD
4.5 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 High incidence of hospital-acquired infections (HAIs)
5.2.1.2 Increasing number of surgical procedures
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED
5.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases
5.2.1.4 Technological advancements in sterilization equipment
5.2.1.5 Growing awareness of environmental & personal hygiene due to COVID-19
5.2.2 MARKET RESTRAINTS
5.2.2.1 Concerns regarding the safety of reprocessed instruments
5.2.2.2 Adverse effects of chemical disinfectants
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare settings
5.2.3.2 Rising adoption of single-use medical nonwovens and devices
5.2.3.3 Growing healthcare industry and outsourcing of operations to emerging countries
FIGURE 22 INDIA: HEALTHCARE SECTOR GROWTH TREND (USD BILLION)
FIGURE 23 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES
5.2.4 MARKET CHALLENGES
5.2.4.1 Complications associated with hospital-acquired infection control procedures
5.2.4.2 End-user noncompliance with sterilization standards
TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS
5.2.4.3 Development of alternative technologies for surface disinfection
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF STERILIZATION USING NO2
6.2.2 ROBOTICS UTILIZATION FOR DISINFECTION
6.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS
6.2.4 LAYERING/BUNDLING IN INFECTION PREVENTION
6.3 REGULATORY ANALYSIS
6.3.1 REGULATORY JURISDICTION
TABLE 6 FDA- AND EPA-REGISTERED PRODUCT CATEGORIES
6.3.2 BY REGION
6.3.2.1 North America
6.3.2.1.1 US
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
6.3.2.1.2 Canada
TABLE 7 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING
6.3.2.2 Europe
TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION
FIGURE 25 CE MARKING FOR REPROCESSED MEDICAL DEVICES
6.3.2.3 Asia Pacific
6.3.2.3.1 Japan
TABLE 9 SOME GUIDELINES FOLLOWED UNDER ISO IN JAPAN
TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES
6.3.2.3.2 Australia
6.3.2.4 Latin America
6.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19
6.3.3.1 Sterilizers
TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS
6.3.3.2 Disinfectant devices
TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES
6.4 TECHNOLOGY ANALYSIS
6.4.1 KEY TECHNOLOGIES
6.4.2 COMPLEMENTARY TECHNOLOGIES
6.4.3 ADJACENT TECHNOLOGIES
6.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 PORTER’S FIVE FORCES ANALYSIS (2020): HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
6.5.1 THREAT FROM NEW ENTRANTS
6.5.2 THREAT FROM SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
6.6 ECOSYSTEM ANALYSIS
FIGURE 26 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS
6.7 VALUE CHAIN ANALYSIS
FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS
6.8 TRADE DATA
6.8.1 EXPORT DATA (USD)
6.8.2 IMPORT DATA (USD)
6.9 PATENT ANALYSIS
6.9.1 PATENT PUBLICATION TRENDS FOR HOSPITAL-ACQUIRED INFECTION CONTROL
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2021)
6.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021)
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021)
TABLE 14 LIST OF FEW PATENTS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, 2020–2021
6.10 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
7 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS
TABLE 16 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
7.2 PROTECTIVE BARRIERS
7.2.1 RISING ADOPTION OF NONWOVENS IN SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH
TABLE 17 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 STERILIZATION
TABLE 18 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 19 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1 STERILIZATION EQUIPMENT
7.3.1.1 Effectiveness of sterilization equipment in sterilizing heat-sensitive products is expected to boost the market growth
TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 STERILIZATION SERVICES
7.3.2.1 Increasing prevalence of HAIs and rising surgical interventions to drive market growth
TABLE 21 STERILIZATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 STERILIZATION CONSUMABLES & ACCESSORIES
7.3.3.1 Low cost and efficacy of sterilization consumables & accessories in monitoring the sterilization process to drive market growth
TABLE 22 STERILIZATION CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 DISINFECTANTS
TABLE 23 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION
TABLE 24 COMMON DISINFECTANTS USED IN HEALTHCARE SETTINGS
TABLE 25 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 DISINFECTANTS, BY TYPE
TABLE 26 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2019–2026 (USD MILLION)
7.4.1.1 Hand disinfectants
7.4.1.1.1 Increasing availability of various hand disinfection options to aid market growth
TABLE 27 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 28 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.2 Surface disinfectants
7.4.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff
TABLE 29 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 30 SURFACE DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.3 Skin disinfectants
7.4.1.3.1 Growing awareness about different HAIs and SSIs to aid market growth
TABLE 31 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 32 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1.4 Instrument disinfectants
7.4.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market
TABLE 33 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT AND THE REQUIRED LEVEL OF REPROCESSING
TABLE 34 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 DISINFECTANTS, BY FORMULATION
TABLE 35 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2019–2026 (USD MILLION)
7.4.2.1 Liquid disinfectants
7.4.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces
TABLE 36 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 37 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2.2 Disinfectant wipes
7.4.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens
TABLE 38 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS
TABLE 39 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2.3 Disinfectant sprays
7.4.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters
TABLE 40 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS
TABLE 41 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 DISINFECTORS
7.5.1 GROWING NEED TO REDUCE THE SPREAD OF HAIS IS DRIVING MARKET GROWTH
TABLE 42 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTORS, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 ENDOSCOPE REPROCESSING PRODUCTS
7.6.1 INCREASING NUMBER OF ENDOSCOPY PROCEDURES CONDUCTED TO DRIVE MARKET GROWTH
TABLE 43 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION)
7.7 OTHER INFECTION CONTROL PRODUCTS
TABLE 44 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER INFECTION CONTROL PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION)
8 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER
8.1 INTRODUCTION
TABLE 45 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 IMPACT OF COVID-19 ON THE END USERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
8.3 HOSPITALS & INTENSIVE CARE UNITS (ICUS)
8.3.1 HIGH PREVALENCE OF HAIS TO DRIVE THE DEMAND FOR DISINFECTION AND STERILIZATION PRODUCTS AMONG HOSPITALS & INTENSIVE CARE UNITS
TABLE 46 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & INTENSIVE CARE UNITS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 AMBULATORY SURGERY & DIAGNOSTIC CENTERS
8.4.1 GROWING NUMBER OF OUTPATIENTS AND AWARENESS OF MINIMALLY INVASIVE SURGERIES IS EXPECTED TO PROPEL MARKET GROWTH
TABLE 47 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGERY & DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 NURSING HOMES & MATERNITY CENTERS
8.5.1 GROWING NEED TO ENSURE THE SAFETY OF ELDERLY PATIENTS AND RISING SURGICAL PROCEDURES IN WOMEN TO DRIVE THE ADOPTION OF HAI CONTROL PRODUCTS IN THIS END-USER SEGMENT
TABLE 48 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR NURSING HOMES & MATERNITY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER END USERS
TABLE 49 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
9 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 31 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020)
TABLE 50 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
9.3 NORTH AMERICA
TABLE 51 NATIONAL ACUTE CARE HOSPITAL HAI METRICS
FIGURE 32 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
TABLE 52 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 54 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 57 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 US
9.3.1.1 Increasing prevalence of HAIs, high R&D expenditure, and the presence of well-established pharmaceutical, medical devices, and hospital industries to drive market growth
TABLE 59 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 60 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 US: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 US: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 64 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 CANADA
9.3.2.1 High prevalence of HAIs to increase the adoption of infection control products in the country
TABLE 65 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 66 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 CANADA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 70 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 EUROPE
TABLE 71 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 72 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 73 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 EUROPE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 77 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 GERMANY
9.4.1.1 Rising incidence of nosocomial infections and chronic diseases to drive growth in the market in Germany
TABLE 78 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 79 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 GERMANY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 GERMANY: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 83 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 FRANCE
9.4.2.1 High healthcare spending in the country to favor market growth
TABLE 84 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 85 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 FRANCE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 FRANCE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 89 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 UK
9.4.3.1 Rising number of surgical procedures to drive the market growth in the UK
TABLE 90 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 91 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 UK: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 UK: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 95 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 ITALY
9.4.4.1 Improving quality and accessibility to medical care and technologies to support market growth
TABLE 96 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 97 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 99 ITALY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ITALY: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 101 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.5 SPAIN
9.4.5.1 Rising incidence of chronic disorders to drive market growth
TABLE 102 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 103 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 SPAIN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 SPAIN: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 107 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.6 REST OF EUROPE
TABLE 108 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 109 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ROE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 113 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
TABLE 114 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 JAPAN
9.5.1.1 Rising standard of care due to the increasing healthcare expenditure to support market growth
TABLE 121 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 122 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 CHINA
9.5.2.1 China is the fastest-growing market for hospital-acquired infection control products and services
FIGURE 34 CHINA: TOTAL NUMBER OF HOSPITAL BEDS (2009–2019)
TABLE 127 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 128 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 CHINA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 CHINA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 132 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 INDIA
9.5.3.1 Large patient population to support the growth of the hospital-acquired infection control market in the country
TABLE 133 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 134 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 INDIA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 INDIA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 138 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.4 REST OF ASIA PACIFIC
FIGURE 35 NUMBER OF INBOUND VISITORS TO SOUTH KOREA FROM
2000 TO 2020 (IN MILLIONS)
TABLE 139 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 140 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 ROAPAC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 ROAPAC: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 144 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 LATIN AMERICA
9.6.1 RISING NUMBER OF COSMETIC SURGERIES IN THE REGION TO DRIVE THE ADOPTION OF INFECTION CONTROL PRODUCTS
TABLE 145 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 146 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 LATIN AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 LATIN AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 150 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.7 MIDDLE EAST & AFRICA
9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
TABLE 151 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 37 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2020
TABLE 157 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE BENCHMARKING
10.5.1 COMPANY PRODUCT/SERVICE FOOTPRINT
TABLE 158 COMPANY PRODUCT OFFERING FOOTPRINT (20 COMPANIES)
TABLE 159 COMPANY END-USER FOOTPRINT (20 COMPANIES)
TABLE 160 COMPANY REGION FOOTPRINT (20 COMPANIES)
10.6 COMPETITIVE LEADERSHIP MAPPING
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 38 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 161 PRODUCT LAUNCHES & APPROVALS, 2018–2021
10.7.2 DEALS
TABLE 162 DEALS, 2018–2021
10.7.3 OTHER DEVELOPMENTS
TABLE 163 OTHER DEVELOPMENTS, 2018–2021
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 STERIS PLC
TABLE 164 STERIS PLC: BUSINESS OVERVIEW
FIGURE 39 STERIS PLC: COMPANY SNAPSHOT (2021)
11.1.2 SOTERA HEALTH COMPANY
TABLE 165 SOTERA HEALTH COMPANY: BUSINESS OVERVIEW
FIGURE 40 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT (2020)
11.1.3 GETINGE AB
TABLE 166 GETINGE AB: BUSINESS OVERVIEW
FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020)
11.1.4 ADVANCED STERILIZATION PRODUCTS (ASP)
TABLE 167 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW
FIGURE 42 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020)
11.1.5 ECOLAB INC.
TABLE 168 ECOLAB INC.: BUSINESS OVERVIEW
FIGURE 43 ECOLAB INC.: COMPANY SNAPSHOT (2020)
11.1.6 3M COMPANY
TABLE 169 3M COMPANY: BUSINESS OVERVIEW
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2020)
11.1.7 MATACHANA GROUP
TABLE 170 MATACHANA GROUP: BUSINESS OVERVIEW
11.1.8 MMM GROUP
TABLE 171 MMM GROUP: BUSINESS OVERVIEW
11.1.9 BELIMED AG (A SUBSIDIARY OF METALL ZUG GROUP)
TABLE 172 BELIMED AG: BUSINESS OVERVIEW
FIGURE 45 METALL ZUG GROUP: COMPANY SNAPSHOT (2020)
11.1.10 RECKITT BENCKISER
TABLE 173 RECKITT BENCKISER: BUSINESS OVERVIEW
FIGURE 46 RECKITT BENCKISER: COMPANY SNAPSHOT (2020)
11.1.11 METREX RESEARCH LLC (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 174 METREX RESEARCH: BUSINESS OVERVIEW
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.12 MIELE GROUP
TABLE 175 MIELE GROUP: BUSINESS OVERVIEW
FIGURE 48 MIELE GROUP: COMPANY SNAPSHOT (2020)
11.1.13 PAL INTERNATIONAL
TABLE 176 PAL INTERNATIONAL: BUSINESS OVERVIEW
11.1.14 MELAG MEDIZINTECHNIK GMBH & CO. KG
TABLE 177 MELAG MEDIZINTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
11.1.15 CONTEC, INC.
TABLE 178 CONTEC, INC.: BUSINESS OVERVIEW
11.1.16 MEDALKAN
TABLE 179 MEDALKAN: BUSINESS OVERVIEW
11.1.17 SYSTEC GMBH
TABLE 180 SYSTEC GMBH: BUSINESS OVERVIEW
11.1.18 C.B.M. S.R.L. MEDICAL EQUIPMENT
TABLE 181 C.B.M. S.R.L. MEDICAL EQUIPMENT: BUSINESS OVERVIEW
11.1.19 CONTINENTAL EQUIPMENT COMPANY
TABLE 182 CONTINENTAL EQUIPMENT COMPANY: BUSINESS OVERVIEW
11.1.20 BETA-GAMMA-SERVICE GMBH & CO. KG
TABLE 183 BETA-GAMMA-SERVICE GMBH & CO. KG: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 MIDWEST STERILIZATION CORPORATION
11.2.2 BLUE LINE STERILIZATION SERVICES LLC
11.2.3 STERIPACK GROUP
11.2.4 STERI-TEK
11.2.5 STERILIZATION SERVICES
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
